UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055658
Receipt number R000063420
Scientific Title Operation of Locobot for Improvement of Postoperative Balance Function in Patients With Cervical Spondylotic Myelopathy
Date of disclosure of the study information 2024/09/28
Last modified on 2026/01/29 15:30:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Operation of Locobot for Improvement of Postoperative Balance Function in Patients With Cervical Spondylotic Myelopathy

Acronym

Operation of Locobot for Improvement of Postoperative Balance Function in Patients With Cervical Spondylotic Myelopathy

Scientific Title

Operation of Locobot for Improvement of Postoperative Balance Function in Patients With Cervical Spondylotic Myelopathy

Scientific Title:Acronym

Operation of Locobot for Improvement of Postoperative Balance Function in Patients With Cervical Spondylotic Myelopathy

Region

Japan


Condition

Condition

cervical spondylotic myelopathy

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to prove the usefulness of locobot as balance training in postoperative rehabilitation of patients with cervical spondylotic myelopathy, to prevent falls and secondary neck disorders, and to contribute to the improvement of manpower shortages in the medical field by introducing robots.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Movement of the center of gravity of the body in the open eye and close eye standing position

Twice of preoperative and on day 11 or 12 postoperative

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

weight-shifting-based robot control system ("locobot") is used as balance training for postoperative patients with cervical spondylotic myelopathy.

Interventions/Control_2

Conventional methods will be used as balance training for postoperative patients with cervical spondylotic myelopathy.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Patients who are 20 years of age or older at the time of consent; (2) Patients who underwent vertebroplasty during hospitalization; (3) Patients who were able to perform all endpoints before and after surgery; (4) Patients who have been fully informed about their participation in this study, and who have given their free, written consent based on their full understanding.

Key exclusion criteria

(1) Subjects with traumatic spinal cord injury, spinal cord infection, pathological musculoskeletal disease, or other neurological disease (2) Subjects with orthopedic problems that may affect the performance of the assessment items (3) Subjects with balance disorders not caused by CSM such as vestibular dysfunction (4) Subjects who cannot perform all assessment items during preoperative and postoperative assessments (5) Subjects with higher brain dysfunction or cognitive impairment (6) Subjects with other conditions that make them unsuitable as research subjects(5) Subjects with higher brain dysfunction or cognitive impairment (6) Other subjects deemed inappropriate as research subjects by the principal investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name hideki
Middle name
Last name arakawa

Organization

Rehabilitation Unit, University of Miyazaki Hospital, Miyazaki, Japan

Division name

Rehabilitation Unit, University of Miyazaki Hospital, Miyazaki, Japan

Zip code

8891601

Address

5200 Kihara, Kiyotaka, Miyazaki City, Miyazaki Prefecture

TEL

0985-85-9849

Email

hideki_arakawa@med.miyazaki-u.ac.jp


Public contact

Name of contact person

1st name tsubasa
Middle name
Last name kawaguchi

Organization

Rehabilitation Unit, University of Miyazaki Hospital, Miyazaki, Japan

Division name

Rehabilitation Unit, University of Miyazaki Hospital, Miyazaki, Japan

Zip code

8891601

Address

5200 Kihara, Kiyotaka, Miyazaki City, Miyazaki Prefecture

TEL

0985-85-9849

Homepage URL


Email

tsubasa_kawaguchi@med.miyazaki-u.ac.jp


Sponsor or person

Institute

Rehabilitation Unit, University of Miyazaki Hospital, Miyazaki, Japan

Institute

Department

Personal name



Funding Source

Organization

Rehabilitation Unit, University of Miyazaki Hospital, Miyazaki, Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

miyazaki university hospital clinical education support center

Address

5200 Kihara, Kiyotake-cho, Miyazaki City, Miyazaki Prefecture

Tel

0985-85-9403

Email

igakubu_kenkyu@med.miyazaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2024 Year 05 Month 21 Day

Date of IRB

2024 Year 09 Month 20 Day

Anticipated trial start date

2024 Year 10 Month 01 Day

Last follow-up date

2026 Year 01 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 09 Month 28 Day

Last modified on

2026 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063420